Latin America Autologous Cell Therapy Market Size & Outlook
Latin America autologous cell therapy market highlights
- The Latin America autologous cell therapy market generated a revenue of USD 320.4 million in 2024.
- The market is expected to grow at a CAGR of 20.4% from 2025 to 2030.
- In terms of segment, cancer was the largest revenue generating application in 2024.
- Cancer is the most lucrative application segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2024 | USD 320.4 million |
| Market revenue in 2030 | USD 1,000.7 million |
| Growth rate | 20.4% (CAGR from 2025 to 2030) |
| Largest segment | Cancer |
| Fastest growing segment | Cancer |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cancer |
Other key industry trends
- In terms of revenue, Latin America region accounted for 5.9% of the global autologous cell therapy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,474.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Autologous Cell Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Tego Science | View profile | 11-50 | Gangneung, Kangwon-do, South Korea, Asia | http://www.tegoscience.com |
| Caladrius Biosciences | View profile | - | - | |
| Opexa Therapeutics | View profile | 11-50 | Houston, Texas, United States, North America | http://www.opexatherapeutics.com |
| Catalent, Inc | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| Bristol Myers Squibb | View profile | - | - | - |
| Corning Incorporated | View profile | - | Corning, New York, United States, North America | https://www.corning.com/ |
| Brainstorm Cell Therapeutics Inc | View profile | 29 | 1325 Avenue of Americas, 28th Floor, New York, NY, United States, 10019 | https://www.brainstorm-cell.com |
| Holostem Terapie Avanzate | View profile | 11-50 | Modena, Emilia-Romagna, Italy, Europe | https://www.holostem.com/ |
| Pharmicell | View profile | 51-100 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea, Asia | http://www.pharmicell.com/ |
| Bio Elpida | View profile | 11-50 | Lyon, Rhone-Alpes, France, Europe | http://www.bio-elpida.com |
| Vericel Corp | View profile | 314 | 64 Sidney Street, Cambridge, MA, United States, 02139 | https://www.vcel.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Latin America autologous cell therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autologous cell therapy market will help companies and investors design strategic landscapes.
Cancer was the largest segment with a revenue share of 123.38% in 2024. Horizon Databook has segmented the Latin America autologous cell therapy market based on cancer covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Latin America autologous cell therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America autologous cell therapy market databook
-
Our clientele includes a mix of autologous cell therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America autologous cell therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America autologous cell therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
